Back

The utility of the MAGGIC heart failure risk score in predicting response to spironolactone: validation and results from the TOPCAT trial

27 May 2019 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Chronic Heart Failure – Epidemiology, Prognosis, Outcome Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2019

About the speaker

Photo
Doctor Daniel Silverman

Medical University of South Carolina, Charleston (United States of America)

27 More presentations in this session

Presentation thumbnail
Doctor W. Teh (Birmingham, GB)
Abstract Slides
Presentation thumbnail
Presentation thumbnail
Miss R. Mo (Beijing, CN)
Abstract
Presentation thumbnail
Doctor A. Cannata (London, GB)
Abstract Slides
Presentation thumbnail
Doctor E. Santiago Vacas (El Masnou, ES)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Chronic Heart Failure – Epidemiology, Prognosis, Outcome

The Event

Event poster

Heart Failure 2019

27 May 2019 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources